Alteration and Significance of Heparin-Binding Epidermal-Growth-Factor-Like Growth Factor in Psoriatic Epidermis

Publisher： Karger

E-ISSN： 1421-9832|207|1|22-27

ISSN： 1018-8665

Source： Dermatology, Vol.207, Iss.1, 2003-07, pp. : 22-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor

By  

Dermatology, Vol. 225, Iss. 2, 2012-09 ,pp. : 135-140

Karger

Access to resources Recommend Favorite

Density of Demodex folliculorum in Patients Receiving Epidermal Growth Factor Receptor Inhibitors

By  

Dermatology, Vol. 222, Iss. 2, 2011-02 ,pp. : 144-147

Karger

Access to resources Recommend Favorite

Salivary Epidermal Growth Factor Levels in Behçet’s Disease and Recurrent Aphthous Stomatitis

By  

Dermatology, Vol. 217, Iss. 3, 2008-07 ,pp. : 235-240

Karger

Access to resources Recommend Favorite

Development of Multiple Paronychia and Periungual Granulation in Patients Treated with Gefitinib, an Inhibitor of Epidermal Growth Factor Receptor

By  

Dermatology, Vol. 207, Iss. 3, 2003-10 ,pp. : 324-325

Karger

Access to resources Recommend Favorite

Azithromycin Pulses for the Treatment of Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption: An Effective and Convenient Alternative to Tetracyclines

By  

Dermatology, Vol. 224, Iss. 4, 2012-06 ,pp. : 315-319

Karger

Access to resources Recommend Favorite